Hindrances in Legalizing Medicinal Cannabis [transcript][audio]

Guest: Stewart Washer  

Presenter: Wayne Bucklar

Guest Bio: Dr Stewart Washer is the Executive Director of listed medicinal cannabis research company, Zelda Therapeutics Ltd (ASX:ZLD). With more than 25 years of leadership experience in medical and agri food biotech companies, Stewart can shed light on medicinal cannabis’ current political and scientific landscapes, both nationally and globally. Stewart is also Chairman of Orthocell Ltd (ASX:OCC), a regenerative medicine company, Founding Chairman and current Director of Cynata Therapeutics Ltd (ASX:CYP) who are developing global stem cell therapies, Chairman of Minomic International Ltd, and a founder and consultant to AusCann Ltd (ASX:AC8).

Segment overview: Zelda Therapeutics works on legalizing medicinal cannabis and brings together some of the world’s leading researchers and clinicians active in the study and use of medicinal cannabis to treat complex diseases. In this interview, Dr Washer talks about the current constraints and misconceptions that are hindering the development of the medicinal cannabis sector. He also points out the difference between medicinal cannabis that is accessible through street providers, and what will be available through pharmaceutical companies.

Liked it? Take a second to support healthprofessionalradio on Patreon!


Leave a Reply

You must be logged in to post a comment.